↓ Skip to main content

Gemcitabine-based versusfluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study

Overview of attention for article published in BMC Cancer, December 2008
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Gemcitabine-based versusfluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
Published in
BMC Cancer, December 2008
DOI 10.1186/1471-2407-8-374
Pubmed ID
Authors

Mi-Jung Kim, Do-Youn Oh, Se-Hoon Lee, Dong-Wan Kim, Seock-Ah Im, Tae-You Kim, Dae Seog Heo, Yung-Jue Bang

Abstract

There is no standard palliative chemotherapy regimen in biliary tract cancers (BTC). Fluoropyrimidine or gemcitabine, with or without platinum, are most frequently used. We conducted this study to clarify the efficacy of palliative chemotherapy in BTC.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 4%
United States 1 4%
Unknown 26 93%

Demographic breakdown

Readers by professional status Count As %
Other 5 18%
Student > Ph. D. Student 4 14%
Student > Doctoral Student 3 11%
Professor > Associate Professor 3 11%
Researcher 3 11%
Other 3 11%
Unknown 7 25%
Readers by discipline Count As %
Medicine and Dentistry 15 54%
Biochemistry, Genetics and Molecular Biology 2 7%
Agricultural and Biological Sciences 1 4%
Nursing and Health Professions 1 4%
Unknown 9 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2013.
All research outputs
#15,266,089
of 22,701,287 outputs
Outputs from BMC Cancer
#4,100
of 8,256 outputs
Outputs of similar age
#139,966
of 167,088 outputs
Outputs of similar age from BMC Cancer
#34
of 41 outputs
Altmetric has tracked 22,701,287 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,256 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,088 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.